Abstract:Objective To assess the therapeutic effect of plum-blossom needle tapping combined with topical imiquimod immunotherapy on cutaneous squamous cell carcinoma (SCC) in SKH-1 mice,and to explore the immunological mechanism.Methods A total of 40 SKH-1 mice with ultraviolet light-induced cutaneous SCC were randomly and equally divided into 4 groups:control group receiving no treatment,plum-blossom needle group receiving plum-blossom needle tapping on all the tumors once a day,imiquimod group topically treated with imiquimod 5％ cream at a dose of 1.2 g/kg once a day,combination group firstly treated with plum-blossom needle tapping on all the tumors,and after the stop of bleeding topically treated with imiquimod 5％ cream at the same dose as the imiquimod group once a day.All the mice were treated for 30 days.Morphological changes of tumors in all groups were photographed and recorded every day.The tumor size was measured once every three days,and changes of total tumor volume and survival rate of the mice were compared among the 4 groups.At the end of treatment,tunor tissues were resected,and histopathological changes were compared among the 4 groups.Real-time fluorescence-based quantitative PCR (qRT-PCR) was performed to measure the mRNA expression of interferon-α (IFN-α),IFN-β,interleukin-1β (IL-1β),tumor necrosis factor-α (TNF-o) and IL-12 in tumor tissues.Results In the combination group,tumors on the back of mice grew slowly,and some even regressed.However,tumors grew fast in the control group,plum-blossom needle group and imiquimod group,and grew more slowly in the plum-blossom needle group and imiquimod group than in the control group.Before the treatment,there was no significant difference in the total tumor volume among the 4 groups (F =0.90,P ＞ 0.05).After 24-day treatment,the total tumor volume significantly differed among the 4 groups (F =5.16,P ＜ 0.05).The LSD-t test showed that the total tumor volume significantly decreased in the combination group compared with the control group (P ＜ 0.01),but no significant difference was observed among the other groups (P ＞ 0.05).Log-rank test revealed that survival curves significantly differed among the 4 groups (x2 =8.32,P ＜ 0.05).The survival rate was significantly higher in the combination group than in the control group (x2 =4.62,P =0.03),but did not differ between the plum-blossom needle group or imiquimod group and the control group or combination group (all P ＞ 0.05).Histopathological examination showed atypical cells arranged closely,a large number of tumor cells and some keratin pearls in the control group and plumblossom needle group,few dead tumor cells in the imiquimod group,and plenty of dead tumor cells,mild nuclear atypia and increased keratinization in the combination group.qRT-PCR revealed that the relative mRNA expression levels of IFN-α,IFN-β,IL-12,IL-1β and TNF-α were significantly higher in the combination group than those in the control group,plum-blossom needle group and imiquimod group (P ＜ 0.05).The imiquimod group showed significantly higher mRNA expression of IL-1β than the control group (P ＜ 0.01),but no significant differences were observed among the other groups (P ＞ 0.05).Conclusion Plum-blossom needle tapping can effectively enhance the anti-SCC activity and immunological effects of imiquimod in SKH-1 mice.

Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma

Photodynamic therapy as an alternative treatment in patients with invasive cutaneous SCC where surgery is not feasible: Single center experience

Topical Photodynamic Therapy of Squamous Cell Carcinomas in a Hairless Mouse Model

Therapeutic and immune effects of 5-aminolevulinic acid photodynamic therapy on UVB-induced squamous cell carcinomas in hairless mice.

PD-L1 Blockade Potentiates the Antitumor Effects of ALA-PDT and Optimizes the Tumor Microenvironment in Cutaneous Squamous Cell Carcinoma

Plum-blossom Needle Tapping Enhances the Efficacy of Topical Imiquimod Immunotherapy for Cutaneous Squamous Cell Carcinoma in SKH-1 Mice

Increased CD56 expression after photodynamic therapy indicates an increased natural killer cell count following early photodynamic therapy for cutaneous squamous cell carcinoma

Modified 5‐aminolevulinic Acid Photodynamic Therapy Reduces Pain and Improves Therapeutic Effects in Cutaneous Squamous Cell Carcinoma Mouse Model

Photodynamic Therapy Activated Stat3 Associated Pathways: Targeting Intrinsic Apoptotic Pathways to Increase Pdt Efficacy in Human Squamous Carcinoma Cells

Optimization of the Treatment of Squamous Cell Carcinoma Cells by Combining Photodynamic Therapy with Cold Atmospheric Plasma

Treating Cutaneous Squamous Cell Carcinoma Using 5-Aminolevulinic Acid Polylactic-Co-Glycolic Acid Nanoparticle-Mediated Photodynamic Therapy in A Mouse Model

Mechanisms Underlying the Effect of 5-Aminolevulinic Acid Photodynamic Therapy on Cutaneous Squamous Cell Carcinoma in SKH-1 Mice

CCL8 Enhances Sensitivity of Cutaneous Squamous Cell Carcinoma to Photodynamic Therapy by Recruiting M1 Macrophages.

Inhibition of MAPK Signaling Pathways Enhances Cell Death Induced by 5-Aminolevulinic Acid-Photodynamic Therapy in Skin Squamous Carcinoma Cells

Exosomes from 5-Aminolevulinic Acid Photodynamic Therapy-Treated Squamous Carcinoma Cells Promote Dendritic Cell Maturation.

Laser Immunotherapy for Cutaneous Squamous Cell Carcinoma with Optimal Thermal Effects to Enhance Tumour Immunogenicity

Abstract A139: Antitumor Effects of Improved DC Vaccine with ALA-PDT Induced Immunogenic Apoptotic Cells for Skin Squamous Cell Carcinoma in Mice

Antineoplastic effect of laser immunotherapy in mice with multiple cutaneous squamous cell carcinoma

Combination of vitamin D and photodynamic therapy enhances immune responses in murine models of squamous cell skin cancer

Present and future perspective of photodynamic therapy for cutaneous squamous cell carcinoma

ALA-PDT successfully treated multiple cSCC in situ and AK in a patient with Epidermodysplasia verruciformis